ArticleRespiratory research2026

MXD4 enhances resistance to KRAS G12C-targeted therapy in lung adenocarcinoma by suppressing ACSL4-mediated ferroptosis.

Yanjun Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.